Medicinsk kommentar till REWIND och PIONER-6, GLP-1 hos T2DM riskpatienter. Peter M Nilsson juni 15, 2019 12:34 f m Läs mer »
Hormonutsöndrade celler ändrar funktion vid DM. Experimentell forskn Exeter UK. Human Molecular Genetics juni 15, 2019 12:23 f m Läs mer »
ADA Report. Dapagliflozin (Forxiga) prevention 27-47% for neuropathy in T2DM juni 12, 2019 6:18 e m Läs mer »
ADA Report. Continued exposure to chronic hyperglycemia in T1DM detrimental to developing brain and cognition juni 12, 2019 6:14 e m Läs mer »
ADA Report. STENO-2 with 21 years follow up T2DM. 69% less stroke. 8 years more life expectancy juni 12, 2019 8:01 f m Läs mer »
ADA Report. CAROLINA DPP4-i Tradjenta versus SU glimeperid. CV no difference. but SU 93% more hospitalized for hypoglycemia, juni 12, 2019 7:35 f m Läs mer »
ADA Report. Oral semaglutide GLP-1 T2DM established cardiovascular disease or high cardiovascular risk in PIONEER 6. MACE 21% reduced. All death 49% lower. N Engl J Med juni 11, 2019 10:18 e m Läs mer »
ADA Report. International Consensus on Time-in-Range TIR CGM-Based Targets. juni 11, 2019 9:46 e m Läs mer »
ADA Report. Experts debate delivery time induced 38 w in women with gestational or preexisting diabetes juni 11, 2019 9:33 e m Läs mer »
